Aurora Financial Journal

Medtronic plc. (MDT)

NYSE · Health care · Electromedical & Electrotherapeutic Apparatus · Financial statements, TTM figures and earnings dates

Medtronic plc. reported revenue of $37.54B over the trailing twelve months ended July 31, 2026, with net income of $5.23B. Annual financial statements are available for fiscal years 2013 to 2026, taken from the company's filings with the SEC. The next quarterly results release is estimated for November 17, 2026, based on the company's filing history.

Open interactive financials →

Key financials

USDTTM
2026-07-31
FY2026
2026-04-24
FY2025
2025-04-25
FY2024
2024-04-26
FY2023
2023-04-28
FY2022
2022-04-29
Income statement
Revenue$37.54B$36.36B$33.54B$32.36B$31.23B$31.69B
Gross profit–$23.64B$21.91B$21.15B$20.51B$21.54B
Operating income$6.79B$6.47B$5.96B$5.14B$5.49B$5.75B
Net income$5.23B$4.80B$4.66B$3.68B$3.76B$5.04B
Diluted EPS$4.06$3.73$3.61$2.76$2.82$3.73
Cash flow
Operating cash flow$8.04B$7.33B$7.04B$6.79B$6.04B$7.35B
Capital expenditure$1.90B$1.90B$1.86B$1.59B$1.46B$1.37B
Free cash flow$6.13B$5.43B$5.18B$5.20B$4.58B$5.98B
Balance sheet
Cash and equivalents$1.69B$1.95B$2.22B$1.28B$1.54B$3.71B
Total assets$93.31B$93.03B$91.68B$89.98B$90.95B$90.98B
Total liabilities$42.46B$42.96B$43.42B$39.56B$39.28B$38.26B
Total debt$28.15B$27.96B$28.52B$25.02B$24.36B$24.11B
Shareholders' equity$50.23B$49.46B$48.02B$50.21B$51.48B$52.55B

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in USD as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full MDT page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, the statements exactly as filed with the SEC, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open MDT financials →